JP2021529792A5 - - Google Patents
Info
- Publication number
- JP2021529792A5 JP2021529792A5 JP2020573524A JP2020573524A JP2021529792A5 JP 2021529792 A5 JP2021529792 A5 JP 2021529792A5 JP 2020573524 A JP2020573524 A JP 2020573524A JP 2020573524 A JP2020573524 A JP 2020573524A JP 2021529792 A5 JP2021529792 A5 JP 2021529792A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- hydrogen
- clathrate
- prodrug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024094936A JP2024138260A (ja) | 2018-06-27 | 2024-06-12 | プロテアソーム活性増強化合物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862690563P | 2018-06-27 | 2018-06-27 | |
| US201862690565P | 2018-06-27 | 2018-06-27 | |
| US62/690,563 | 2018-06-27 | ||
| US62/690,565 | 2018-06-27 | ||
| PCT/US2019/039600 WO2020006296A1 (en) | 2018-06-27 | 2019-06-27 | Proteasome activity enhancing compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024094936A Division JP2024138260A (ja) | 2018-06-27 | 2024-06-12 | プロテアソーム活性増強化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021529792A JP2021529792A (ja) | 2021-11-04 |
| JP2021529792A5 true JP2021529792A5 (enExample) | 2022-06-29 |
| JP7561632B2 JP7561632B2 (ja) | 2024-10-04 |
Family
ID=67439356
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020573524A Active JP7561632B2 (ja) | 2018-06-27 | 2019-06-27 | プロテアソーム活性増強化合物 |
| JP2024094936A Withdrawn JP2024138260A (ja) | 2018-06-27 | 2024-06-12 | プロテアソーム活性増強化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024094936A Withdrawn JP2024138260A (ja) | 2018-06-27 | 2024-06-12 | プロテアソーム活性増強化合物 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US11560385B2 (enExample) |
| EP (1) | EP3814338A1 (enExample) |
| JP (2) | JP7561632B2 (enExample) |
| KR (1) | KR20210024588A (enExample) |
| CN (1) | CN112585132B (enExample) |
| AU (1) | AU2019295765B2 (enExample) |
| BR (2) | BR112020026580A2 (enExample) |
| CA (1) | CA3103954A1 (enExample) |
| CL (1) | CL2020003380A1 (enExample) |
| CR (1) | CR20200652A (enExample) |
| IL (1) | IL279698A (enExample) |
| MA (1) | MA53014A (enExample) |
| MX (1) | MX2020014082A (enExample) |
| PE (1) | PE20211804A1 (enExample) |
| PH (1) | PH12020552261A1 (enExample) |
| SG (1) | SG11202013026WA (enExample) |
| WO (1) | WO2020006296A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112654621B (zh) | 2018-06-27 | 2024-05-14 | 百时美施贵宝公司 | 可作为t细胞活化剂的经取代萘啶酮化合物 |
| LT3860998T (lt) | 2018-10-05 | 2024-06-25 | Annapurna Bio Inc. | Junginiai ir kompozicijos, skirti gydyti būkles, susijusias su apj receptoriaus aktyvumu |
| CN111423353B (zh) * | 2020-04-29 | 2022-03-22 | 湖北省生物农药工程研究中心 | 多取代n-芳基吡咯类化合物及其制备方法 |
| CN112142642B (zh) * | 2020-10-15 | 2022-03-04 | 华侨大学 | 一种1,2,3-三取代-5-三氟甲基吡咯衍生物的制备方法 |
| WO2023107597A2 (en) * | 2021-12-08 | 2023-06-15 | Kineta, Inc. | Bicyclic heteroaromatic amide compounds and uses thereof |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1142508A (en) | 1966-04-27 | 1969-02-12 | Whitefin Holding Sa | Pyrrole derivatives |
| GB1154743A (en) | 1966-05-17 | 1969-06-11 | Whitefin Holding Sa | Aminoethanols |
| AP9801302A0 (en) | 1997-07-23 | 2000-01-23 | Pfizer | Indole compounds as anti-inflammatory/analgesic agents.. |
| AU2337499A (en) | 1998-01-23 | 1999-08-09 | National Jewish Medical And Research Center | Method for treating inflammatory diseases using heat shock proteins |
| US7842470B2 (en) | 2001-10-09 | 2010-11-30 | Oregon Health & Science University | Method for pharmacoperones correction of GnRHR mutant protein misfolding |
| US20060148767A1 (en) | 2001-12-06 | 2006-07-06 | George Cioca | Use of acyl salicylates as heat shock inducers |
| US20050137223A1 (en) | 2003-11-12 | 2005-06-23 | Amicus Therapeutics, Inc. | Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease |
| EP3782655A1 (en) | 2005-05-17 | 2021-02-24 | Amicus Therapeutics, Inc. | A method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives |
| ES2485369T3 (es) | 2005-06-08 | 2014-08-13 | Amicus Therapeutics, Inc. | Tratamiento de trastornos del SNC asociados con mutaciones en genes que codifican enzimas lisosómicas |
| WO2007098229A2 (en) | 2006-02-21 | 2007-08-30 | Michigan State University | Geldanamycin derivatives and method of use thereof |
| WO2007131034A1 (en) | 2006-05-03 | 2007-11-15 | The Regents Of The University Of Michigan | Pyrimidone derivatives which are modulators of heat shock protein (hsp) 70 |
| MX351004B (es) | 2006-05-16 | 2017-09-26 | Nat Institutes Of Health | Ensayos para diagnosticar y evaluar opciones de tratamiento para enfermedad de fabry. |
| WO2007140212A2 (en) | 2006-05-24 | 2007-12-06 | Amicus Therapeutics, Inc. | Tartrate salt of isofagomine and methods of use |
| DK2040548T3 (da) | 2006-06-23 | 2012-08-13 | Amicus Therapeutics Inc | Fremgangsmåde til behandling af neurologiske forstyrrelser ved forøgelse af aktiviteten af beta-glucocerebrosidase |
| US20080119457A1 (en) | 2006-08-24 | 2008-05-22 | Serenex, Inc. | Benzene, Pyridine, and Pyridazine Derivatives |
| ES2524259T3 (es) | 2008-03-24 | 2014-12-04 | Novartis Ag | Inhibidores de metaloproteinasa de matriz a base de arilsulfonamida |
| KR20120117905A (ko) * | 2010-01-28 | 2012-10-24 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 프로테아좀 활성을 향상시키는 조성물 및 방법 |
| TR201906779T4 (tr) | 2011-05-12 | 2019-05-21 | Proteostasis Therapeutics Inc | Proteostaz regülatörleri. |
| WO2014116228A1 (en) * | 2013-01-25 | 2014-07-31 | President And Fellows Of Harvard College | Usp14 inhibitors for treating or preventing viral infections |
| WO2014203150A1 (en) | 2013-06-17 | 2014-12-24 | Lupin Limited | Pyrrole derivatives as alpha 7 nachr modulators |
| FR3008977A1 (fr) | 2013-07-23 | 2015-01-30 | Servier Lab | Nouveaux derives d'isoindoline ou d'isoquinoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| WO2015073528A1 (en) | 2013-11-12 | 2015-05-21 | Proteostasis Therapeutics, Inc. | Proteasome activity enhancing compounds |
-
2019
- 2019-06-27 WO PCT/US2019/039600 patent/WO2020006296A1/en not_active Ceased
- 2019-06-27 BR BR112020026580-2A patent/BR112020026580A2/pt unknown
- 2019-06-27 BR BR122023023216-0A patent/BR122023023216A2/pt unknown
- 2019-06-27 CN CN201980055152.2A patent/CN112585132B/zh not_active Expired - Fee Related
- 2019-06-27 CR CR20200652A patent/CR20200652A/es unknown
- 2019-06-27 EP EP19744945.7A patent/EP3814338A1/en not_active Withdrawn
- 2019-06-27 SG SG11202013026WA patent/SG11202013026WA/en unknown
- 2019-06-27 KR KR1020217002233A patent/KR20210024588A/ko not_active Ceased
- 2019-06-27 PE PE2020002159A patent/PE20211804A1/es unknown
- 2019-06-27 MX MX2020014082A patent/MX2020014082A/es unknown
- 2019-06-27 MA MA053014A patent/MA53014A/fr unknown
- 2019-06-27 JP JP2020573524A patent/JP7561632B2/ja active Active
- 2019-06-27 CA CA3103954A patent/CA3103954A1/en active Pending
- 2019-06-27 AU AU2019295765A patent/AU2019295765B2/en not_active Ceased
-
2020
- 2020-12-23 US US17/133,372 patent/US11560385B2/en active Active
- 2020-12-23 IL IL279698A patent/IL279698A/en unknown
- 2020-12-23 CL CL2020003380A patent/CL2020003380A1/es unknown
- 2020-12-23 PH PH12020552261A patent/PH12020552261A1/en unknown
-
2022
- 2022-11-18 US US18/057,020 patent/US12319698B2/en active Active
-
2024
- 2024-06-12 JP JP2024094936A patent/JP2024138260A/ja not_active Withdrawn